General Information - malecare.org

Provenge Comes Closer to European Union Approval for Men with Advanced Prostate Cancer

It was announced today that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that PROVENGE® (autologous peripheral blood mononuclear cells activated with PAP-GM-CSF or Sipuleucel-T) be granted marketing authorization in the European Union (EU), for the treatment of asymptomatic or minimally symptomatic metastatic (non-visceral) [...]

By Malecare|2013-06-28T09:05:09-04:00June 28th, 2013|Advanced Prostate Cancer, CHMP, Drugs & Treatments, General Information, Provenge, Uncategorized, Understanding APC, vaccines|2 Comments

On the Horizon – Many More Novel Drugs for the Treatment of Advanced Prostate Cancer

There have been many potential targets identified for the treatment of advanced prostate cancer. Many of these targets are being actively explored with clinical trials designed to test some inhibitors of the targets. Antisense oligonucleotides (OGX-011) targets clusterin, a chaperone protein and OGX-427 which targets heat-shock protein 27 are among the inhibitors being evaluated. OGX-011 [...]

By Malecare|2017-10-19T10:49:43-04:00June 27th, 2013|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Combination Therapy, Custirsen, Drugs & Treatments, General Information, On The Horizon, Tasquinimod (TASQ), Uncategorized, Understanding APC|0 Comments

PET/MR Imaging More Efficacious for Mapping Recurrent Prostate Cancer

Approximately one third of all men diagnosed and treated for prostate cancer will experience a recurrence of their prostate cancer! This is a shocking number, but it is a true number. It does not matter what the treatment a man has, the statistic holds up across all treatments. The first sign of a problem, a [...]

By Malecare|2020-02-04T10:44:08-05:00June 18th, 2013|adjuvant therapy, Advanced Prostate Cancer, Bio Chemical Recurrence, Choline C11, General Information, Research, salvage therapy, Uncategorized, Understanding APC|0 Comments

DOD PCRP Gets Funded for the 2014 Budget Year

I have often discussed the importance of the Prostate Cancer Research Program (PCRP), which is a part of the Department of Defense (DOD) Medical Research Program. The program is geared to delivering funding for prostate cancer research that is translational, or will be quickly interpreted in the clinic. Like all other government funding it very [...]

By Malecare|2021-02-17T10:43:15-05:00June 14th, 2013|Advanced Prostate Cancer, Advocacy, DOD, Financial, General Information, Politics of Cancer, Research, Start A Cure, Uncategorized|0 Comments

Important – Read the Prescribing Information that Comes with Your Medications

The following is a post from Chuck Maack on the Advanced Prostate Cancer Internet support group: “It came to mind wondering how many patients and/or their caregivers prescribed Zytiga/abiraterone acetate have ever taken the important time to read all the details regarding the effects that may be experienced by patients and whether or not they [...]

By Malecare|2021-02-17T10:43:06-05:00May 23rd, 2013|Advanced Prostate Cancer, Drugs & Treatments, General Information, Prostate Ponderings, Uncategorized, Understanding APC|2 Comments